CPRX: Catalyst Pharmaceuticals Inc. Stocks News on April 19, 2025

CPRX

Argus Research

4 days ago

CPRX: Raising target price to $24.00

CPRX

Insider Monkey

8 days ago

Is Catalyst Pharmaceuticals, Inc. (CPRX) the Best Russell 2000 Stock to Buy According to Wall Street Analysts?

Why Is Nektar (NKTR) Down 38.8% Since Last Earnings Report?

CPRX

Zacks

8 days ago

Why Is Nektar (NKTR) Down 38.8% Since Last Earnings Report?

CPRX

Simply Wall St.

10 days ago

Catalyst Pharmaceuticals (NasdaqCM:CPRX) Navigates Market Volatility With 3% Dip

CPRX

Argus Research

11 days ago

CPRX: Lowering target price to $22.00

Rhythm Pharmaceuticals Stock Earns RS Rating Upgrade

CPRX

Investor's Business Daily

11 days ago

Rhythm Pharmaceuticals Stock Earns RS Rating Upgrade

Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals

CPRX

GlobeNewswire

11 days ago

Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals

CPRX

Insider Monkey

17 days ago

What Makes Catalyst Pharmaceuticals (CPRX) an Investment Choice?

CPRX

Argus Research

18 days ago

CPRX: Lowering target price to $25.00

CPRX

Zacks

22 days ago

Catalyst (CPRX) Up 14.7% Since Last Earnings Report: Can It Continue?

Catalyst Pharma Battles To All-Time High After Huge Patent Lawsuit Win

CPRX

Investor's Business Daily

23 days ago

Catalyst Pharma Battles To All-Time High After Huge Patent Lawsuit Win

CPRX

Insider Monkey

23 days ago

Jim Cramer on Catalyst Pharmaceuticals (CPRX): ‘That’s My Kind of Stock!’

CPRX

Argus Research

25 days ago

CPRX: Raising target price to $27.00

CPRX

Simply Wall St.

25 days ago

With 81% ownership in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX), institutional investors have a lot riding on the business

CPRX

Zacks

25 days ago

Catalyst (CPRX) Surges 6.2%: Is This an Indication of Further Gains?

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

CPRX

Zacks

a month ago

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

CPRX

Insider Monkey

a month ago

Is Catalyst Pharmaceuticals, Inc. (CPRX) the Best Healthcare Stock For Long-Term Investment?

CPRX

Simply Wall St.

a month ago

We Think Catalyst Pharmaceuticals' (NASDAQ:CPRX) Robust Earnings Are Conservative

CPRX

Argus Research

2 months ago

CPRX: Raising target price to $24.00

Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference

CPRX

GlobeNewswire

2 months ago

Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference

Catalyst Pharmaceuticals Full Year 2024 Earnings: Beats Expectations

CPRX

Simply Wall St.

2 months ago

Catalyst Pharmaceuticals Full Year 2024 Earnings: Beats Expectations

CPRX

GuruFocus.com

2 months ago

Catalyst Pharmaceuticals Inc (CPRX) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ...

Here's What's Driving Catalyst Pharmaceuticals Stock 8% Higher Today

CPRX

Motley Fool

2 months ago

Here's What's Driving Catalyst Pharmaceuticals Stock 8% Higher Today

CPRX

Zacks

2 months ago

Catalyst (CPRX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

CPRX

Zacks

2 months ago

Catalyst Pharmaceutical (CPRX) Tops Q4 Earnings and Revenue Estimates

CPRX

Associated Press Finance

2 months ago

Catalyst: Q4 Earnings Snapshot

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

CPRX

GlobeNewswire

2 months ago

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

CPRX

GuruFocus.com

2 months ago

Catalyst Pharmaceuticals Inc (CPRX) Q4 2024: Everything You Need To Know Ahead Of Earnings

CPRX

Argus Research

2 months ago

CPRX: Rating increased to a BUY

CPRX

Argus Research

2 months ago

CPRX: What does Argus have to say about CPRX?

Recursion Pharmaceuticals Stock Scores RS Ratings Over 90

CPRX

Investor's Business Daily

2 months ago

Recursion Pharmaceuticals Stock Scores RS Ratings Over 90

Incyte Stock Sees Relative Strength Rating Rise To 71

CPRX

Investor's Business Daily

2 months ago

Incyte Stock Sees Relative Strength Rating Rise To 71

CPRX

Simply Wall St.

2 months ago

Those who invested in Catalyst Pharmaceuticals (NASDAQ:CPRX) five years ago are up 374%

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025

CPRX

GlobeNewswire

2 months ago

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025

CPRX

Argus Research

2 months ago

CPRX: What does Argus have to say about CPRX?

This Drug Stock Sits On A Strong Earnings Foundation As It Tests New Entry

CPRX

Investor's Business Daily

3 months ago

This Drug Stock Sits On A Strong Earnings Foundation As It Tests New Entry

Harmony Biosciences Stock Scores 80-Plus RS Rating

CPRX

Investor's Business Daily

3 months ago

Harmony Biosciences Stock Scores 80-Plus RS Rating

CPRX

Zacks

3 months ago

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

CPRX

Zacks

3 months ago

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

CPRX

Zacks

3 months ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 List of America's Most Successful Mid-Cap Companies

CPRX

GlobeNewswire

3 months ago

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 List of America's Most Successful Mid-Cap Companies

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

CPRX

Zacks

3 months ago

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

CPRX

Argus Research

3 months ago

CPRX: Raising target price to $24.00

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

CPRX

Zacks

3 months ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE® in Japan

CPRX

GlobeNewswire

3 months ago

Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE® in Japan

BeiGene Stock Meets 80-Plus RS Rating Benchmark

CPRX

Investor's Business Daily

3 months ago

BeiGene Stock Meets 80-Plus RS Rating Benchmark

CPRX

Argus Research

3 months ago

CPRX: Raising target price to $23.00

BridgeBio Pharma Stock Earns 87 RS Rating

CPRX

Investor's Business Daily

3 months ago

BridgeBio Pharma Stock Earns 87 RS Rating

CPRX

Zacks

3 months ago

Catalyst (CPRX) Soars 16.7%: Is Further Upside Left in the Stock?

IBD Tech Leader Catalyst Rockets After Striking A Key Deal With Teva

CPRX

Investor's Business Daily

3 months ago

IBD Tech Leader Catalyst Rockets After Striking A Key Deal With Teva

Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Teva Pharmaceuticals

CPRX

GlobeNewswire

3 months ago

Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Teva Pharmaceuticals

CPRX

Zacks

3 months ago

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

CPRX

Zacks

4 months ago

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Arcellx Stock Earns 82 Relative Strength Rating

CPRX

Investor's Business Daily

4 months ago

Arcellx Stock Earns 82 Relative Strength Rating

Neurocrine Biosciences Stock Sees RS Rating Upgrade

CPRX

Investor's Business Daily

4 months ago

Neurocrine Biosciences Stock Sees RS Rating Upgrade

CPRX

Zacks

4 months ago

Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term

CPRX

Argus Research

4 months ago

CPRX: What does Argus have to say about CPRX?

CPRX

Zacks

4 months ago

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock

CPRX

Argus Research

4 months ago

CPRX: What does Argus have to say about CPRX?

Catalyst Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

CPRX

GlobeNewswire

4 months ago

Catalyst Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

NewAmsterdam Pharma Stock Hits 90-Plus RS Rating

CPRX

Investor's Business Daily

4 months ago

NewAmsterdam Pharma Stock Hits 90-Plus RS Rating

CPRX

Argus Research

4 months ago

CPRX: What does Argus have to say about CPRX?

CPRX

Zacks

4 months ago

Why Is Catalyst (CPRX) Down 6.7% Since Last Earnings Report?

CPRX

Argus Research

5 months ago

CPRX: What does Argus have to say about CPRX?

CPRX

Simply Wall St.

5 months ago

Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

CPRX

Zacks

5 months ago

Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term

CPRX

Zacks

5 months ago

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock

Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500™ List

CPRX

GlobeNewswire

5 months ago

Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500™ List

Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences

CPRX

GlobeNewswire

5 months ago

Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences

CPRX

Zacks

5 months ago

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock

Catalyst Pharmaceuticals Recognized Among BioSpace 2025 Best Places to Work

CPRX

GlobeNewswire

5 months ago

Catalyst Pharmaceuticals Recognized Among BioSpace 2025 Best Places to Work

CPRX

Simply Wall St.

5 months ago

Catalyst Pharmaceuticals' (NASDAQ:CPRX) Earnings May Just Be The Starting Point

CPRX

Argus Research

5 months ago

CPRX: Raising target price to $24.00

Vericel Stock Sees RS Rating Shoot Higher

CPRX

Investor's Business Daily

5 months ago

Vericel Stock Sees RS Rating Shoot Higher

CPRX

GuruFocus.com

5 months ago

Catalyst Pharmaceuticals Inc (CPRX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

CPRX

Simply Wall St.

5 months ago

With EPS Growth And More, Catalyst Pharmaceuticals (NASDAQ:CPRX) Makes An Interesting Case

CPRX

Zacks

5 months ago

Catalyst Pharmaceuticals, Inc. (CPRX) Hit a 52 Week High, Can the Run Continue?

CPRX

Zacks

5 months ago

Catalyst (CPRX) Reports Q3 Earnings: What Key Metrics Have to Say

CPRX

Zacks

5 months ago

Catalyst Pharmaceutical (CPRX) Tops Q3 Earnings and Revenue Estimates

CPRX

Associated Press Finance

5 months ago

Catalyst: Q3 Earnings Snapshot

Catalyst Pharmaceuticals Reports Strong Third Quarter 2024 Financial Results and Provides Corporate Update

CPRX

GlobeNewswire

5 months ago

Catalyst Pharmaceuticals Reports Strong Third Quarter 2024 Financial Results and Provides Corporate Update

CPRX

Zacks

5 months ago

CPRX vs. STVN: Which Stock Is the Better Value Option?

CPRX

GuruFocus.com

5 months ago

Catalyst Pharmaceuticals Inc (CPRX) Q3 2024 Earnings Report Preview: What To Look For

CPRX

Argus Research

5 months ago

CPRX: What does Argus have to say about CPRX?

Are Medical Stocks Lagging Bioventus (BVS) This Year?

CPRX

Zacks

5 months ago

Are Medical Stocks Lagging Bioventus (BVS) This Year?

Catalyst Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 6, 2024

CPRX

GlobeNewswire

6 months ago

Catalyst Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 6, 2024

CPRX

Zacks

6 months ago

CPRX or STVN: Which Is the Better Value Stock Right Now?

High Growth Tech Stocks to Watch in October 2024

CPRX

Simply Wall St.

6 months ago

High Growth Tech Stocks to Watch in October 2024

CPRX

Simply Wall St.

6 months ago

With 75% ownership of the shares, Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is heavily dominated by institutional owners

CPRX

Argus Research

6 months ago

CPRX: What does Argus have to say about CPRX?

Catalyst Pharmaceuticals Donates $100,000 to the American Red Cross Hurricane Helene Relief Efforts

CPRX

GlobeNewswire

6 months ago

Catalyst Pharmaceuticals Donates $100,000 to the American Red Cross Hurricane Helene Relief Efforts

CPRX

Zacks

6 months ago

CPRX or STVN: Which Is the Better Value Stock Right Now?

CPRX

Zacks

7 months ago

Catalyst (CPRX) Upgraded to Buy: What Does It Mean for the Stock?

Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024

CPRX

GlobeNewswire

7 months ago

Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024

Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Received Approval to Commercialize FIRDAPSE® in Japan

CPRX

GlobeNewswire

7 months ago

Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Received Approval to Commercialize FIRDAPSE® in Japan

High Growth Tech Stocks In The United States You Should Know

CPRX

Simply Wall St.

7 months ago

High Growth Tech Stocks In The United States You Should Know

CPRX

Simply Wall St.

7 months ago

Despite lower earnings than three years ago, Catalyst Pharmaceuticals (NASDAQ:CPRX) investors are up 293% since then

CPRX

Zacks

7 months ago

Why Is Catalyst (CPRX) Up 8.3% Since Last Earnings Report?

Here's How Much a $1000 Investment in Catalyst Pharmaceutical Made 10 Years Ago Would Be Worth Today

CPRX

Zacks

8 months ago

Here's How Much a $1000 Investment in Catalyst Pharmaceutical Made 10 Years Ago Would Be Worth Today

CPRX

Argus Research

8 months ago

Latest Catalyst Pharmaceuticals Inc. (CPRX) News on April 19, 2025

Share on Social Networks: